Phase 2CompletedAge-related condition
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
A Phase II Randomised, Two-Way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered-Dose (MD) Lotion Doses in Hypogonadal Male Subjects
- Sponsor
- Acrux DDS Pty Ltd (Industry)
- Enrolment
- 40 planned
- Conditions
- Hypogonadism
- Interventions
- Testosterone
- Ages
- adults, older adults
- Registry
- NCT00372008
Full record on ClinicalTrials.gov
From the registry
Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.
Primary outcomes
- Pharmacokinetic
History
Last registry update
Primary completion
Started
Registered